Abstract:β-Arrestins are a family of regulatory and scaffold proteins functioning in signal transduction of G protein-coupled receptors including opioid receptors. Upon agonist stimulation, β-arrestins bind to opioid receptors phosphorylated by G protein-coupled receptor kinases and promote receptor internalization and desensitization. Studies indicated that β-arrestins are required in the development of morphine tolerance in mice. In the current study, we investigated the potential regulatory effects of morphine administration on β-arrestin 1 and β-arrestin 2 mRNA levels in different brain regions in rat using in situ hybridization method. Our results showed that the acute morphine administration (10 mg/kg) resulted in approximately 30% reduction in both β-arrestin 1 and β-arrestin 2 mRNA levels in hippocampus while the chronic morphine treatment (10 mg/kg, b.i.d., for 9 days) caused no significant change in level of either β-arrestin mRNA. In locus coeruleus, both acute and chronic morphine treatments resulted in significant decreases (over 50%) in β-arrestin 1 mRNA level but failed to induce any change in the level of β-arrestin 2 gene expression. The acute morphine administration had no significant effect on β-arrestin 1 or β-arrestin 2 mRNA level in periaqueductal gray and cerebral cortex. However, after chronic morphine treatment, β-arrestin 2 mRNA level decreased by 40% in periaqueductal gray and increased by 25% in cerebral cortex, in strong contrast to the unchanged β-arrestin 1 mRNA level in these two brain regions. Furthermore, spontaneous or naloxone-precipitated withdrawal of morphine that did not affect the level of β-arrestin 1 mRNA resulted in an aberrant increase (100% over control) in β-arrestin 2 mRNA level in hippocampus. Our results thus demonstrated for the first time that opiate administration regulates level of β-arrestin mRNAs in brain and the expression of β-arrestin 1 and β-arrestin 2 subtypes is differentially regulated in locus coeruleus, periaqueductal gray, and cerebral cortex by morphine. These data suggest that β-arrestin 1 and β-arrestin 2 may play different roles in the development of opioid tolerance and dependence.

Enhancement of Morphine Analgesia and Prevention of Morphine Tolerance by Downregulation of Β-Arrestin 2 with Antigene RNAs in Mice.

Improvement of Morphine-Mediated Analgesia by Inhibition of Β-Arrestin 2 Expression in Mice Periaqueductal Gray Matter

Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.

Decreased morphine analgesia in rat overexpressing β-arrestin 2 at periaqueductal gray

Decreased morphine analgesia in rat overexpressing beta-arrestin 2 at periaqueductal gray.

miR-365 targets β-arrestin 2 to reverse morphine tolerance in rats

Β-Arrestin and Morphine Tolerance

Differential regulation of β-arrestin 1 and β-arrestin 2 gene expression in rat brain by morphine

Construction of Expression Vectors Expressing Beta Arrestin 2 Antigene RNAs and Identification of Their Gene Silencing Effects in Vitro

Gene knockdown with lentiviral vector-mediated intrathecal RNA interference of protein kinase C gamma reverses chronic morphine tolerance in rats.

Modulation of Ca2+/calmodulin-dependent Protein Kinase II Activity by Acute and Chronic Morphine Administration in Rat Hippocampus: Differential Regulation of Alpha and Beta Isoforms.

Inhibitory Effect of Spinal Mglu(5) Receptor Antisense Oligonucleotide on the Up-Regulated Expression of Spinal G Protein Associated with Chronic Morphine Treatment.

Mir-873A-5p Targets A20 to Facilitate Morphine Tolerance in Mice

Sirna Capsulated Brain-Targeted Nanoparticles Specifically Knock Down Oatp2b1 In Mice: A Mechanism For Acute Morphine Tolerance Suppression

Role of the spinal NMDA receptor NR2B subunit in inhibition of morphine tolerance by agmatine

MicroRNA-146a Attenuates the Development of Morphine Analgesic Tolerance in a Rat Model

Inhibition of Morphine Tolerance by MrgC Receptor Via Modulation of Interleukin-1Β and Matrix Metalloproteinase 9 in Dorsal Root Ganglia in Rats.

Blockade of Neuronal Dopamine D2 Receptor Attenuates Morphine Tolerance in Mice Spinal Cord

Small G-Protein Rheb Gates Mammalian Target of Rapamycin Signaling to Regulate Morphine Tolerance in Mice.

Src Kinase Inhibition Attenuates Morphine Tolerance without Affecting Reinforcement or Psychomotor Stimulation

miR-219-5p targets CaMKIIγ to attenuate morphine tolerance in rats.